Nightshift work and risk of ovarian cancer

Occupational and Environmental Medicine

Volumn 70, Issue 4, 2013, Pages 231-237

  Bhatti, Parveen ^a   Cushing Haugen, Kara L ^a   Wicklund, Kristine G ^a   Doherty, Jennifer A ^a,b   Rossing, Mary Anne ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NIGHT WORK; OCCUPATIONAL HAZARD; OVARY CARCINOMA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SELF REPORT; SHIFT WORKER; UNITED STATES;

ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; CONFIDENCE INTERVALS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OCCUPATIONAL EXPOSURE; ODDS RATIO; OVARIAN NEOPLASMS; RISK FACTORS; SELF REPORT; TIME FACTORS; WASHINGTON; WORK SCHEDULE TOLERANCE;

ANIMALIA;

EID: 84876043630     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oemed-2012-101146     Document Type: Article

References (31)

1. American Cancer Society. Cancer facts and figures 2012. Atlanta (GA): American Cancer Society, 2012.
2. Hankinson SE, Danforth KN. Ovarian cancer. In: D. Schottendeld and J.F. Fraumeni Cancer epidemiology and prevention. New York: Oxford University Press, 2006:1013-26.
3. Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 2007;8:1065-6.
4. Costa G, Haus E, Stevens R. Shift work and cancer-considerations on rationale, mechanisms, and epidemiology. Scand J Work Environ Health 2010;36:163-79.
5. Mirick DK, Davis S. Melatonin as a biomarker of circadian dysregulation. Cancer Epidemiol Biomarkers Prev 2008;17:3306-13.
6. Lukanova A, Kaaks R. Endogenous hormones and ovarian cancer: Epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 2005;14:98-107.
7. Tamura H, Nakamura Y, Korkmaz A, et al. Melatonin and the ovary: Physiological and pathophysiological implications. Fertil Steril 2009;92:328-43.
8. Erren TC, Reiter RJ, Piekarski C. Light, timing of biological rhythms, and chronodisruption in man. Naturwissenschaften 2003;90:485-94.
9. Chuffa LGA, Amorim JPA, Teixeira GR, et al. Long-term melatonin treatment reduces ovarian mass and enhances tissue antioxidant defenses during ovulation in the rat. Braz J Med Biol Res 2011;44:217-23.
10. Rossing MA, Cushing-Haugen KL, Wicklund KG, et al. Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2548-56.
11. Bodelon C, Cushing-Haugen KL, Wicklund KG, et al. Sun exposure and risk of epithelial ovarian cancer. Cancer Causes Control. 2012;23(12):1985-94.
12. Fritz A. International classification of diseases for oncology ICD-O. 3rd edn. Geneva: WHO Press, 2000.
13. WHO Classification of Tumors. Pathology and genetics of tumours of the breast and female genital organs. Lyon, France: IARC Press, 2003.
14. Gilks CB, Ionescu DN, Kalloger SE, et al. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Hum Pathol 2008;39:1239-51.
15. Gilks CB, Prat J. Ovarian carcinoma pathology and genetics: Recent advances. Hum Pathol 2009;40:1213-23.
16. Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc 1978;73:40-6.
17. Casady RJ, Lepkowski JM. Stratified telephone survey design. Surv Methodol 1993;19:103-13.
18. Megdal SP, Kroenke CH, Laden F, et al. Night work and breast cancer risk: A systematic review and meta-analysis. Eur J Cancer 2005;41:2023-32.
19. Kurian AW, Balise RR, McGuire V, et al. Histologic types of epithelial ovarian cancer: Have they different risk factors? Gynecol Oncol 2005;96:520-30.
20. Pearce CL, Templeman C, Rossing MA, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: A pooled analysis of case-control studies. Lancet Oncol 2012;13:385-94.
21. Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and body size: Individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med 2012;9:e1001200.
22. Saksvik IB, Bjorvatn B, Hetland H, et al. Individual differences in tolerance to shift work-a systematic review. Sleep Med Rev 2011;15:221-35.
23. Poole EM, Schernhammer ES, Tworoger SS. Rotating night shift work and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 2011;20:934-8.
24. Schernhammer ES, Kroenke CH, Laden F, et al. Night work and risk of breast cancer. Epidemiology 2006;17:108-11.
25. Schernhammer ES, Laden F, Speizer FE, et al. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 2003;95:825-8.
26. Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of endometrial cancer. Cancer Res 2007;67:10618-22.
27. Moore CB, Siopes TD. Spontaneous ovarian adenocarcinoma in the domestic turkey breeder hen (Meleagris gallopavo): Effects of photoperiod and melatonin. Neuro Endocrinol Lett 2004;25:94-101.
28. Chuffa LGA, Amorim JPA, Teixeira GR, et al. Long-term exogenous melatonin treatment modulates overall feed efficiency and protects ovarian tissue against injuries caused by ethanol-induced oxidative stress in adult UChB rats. Alcohol Clin Exp Res 2011;35:1498-508.
29. McMenamin T. A time to work: Recent trends in shift work and flexible schedules. Monthly Labor Review 2007;130:3-15.
30. Stevens RG, Hansen J, Costa G, et al. Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med 2011;68:154-62.
31. Di Milia L, Smith PA, Folkard S. A validation of the revised circadian type inventory in a working sample. Pers Individual Differences 2005;39:1293-305.